Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug ...

AI and its potential impact on genomics research and clinical practice was peppered throughout this year's Festival of Genomics ...

Clinical trials for exa-cel have shown promising results that it has been authorised by the FDA and MHRA for use in beta thalassemia and sickle cell disease. These successes make CRISPR technology, as ...

Dr. Khoury is the founding Director of the Office of Public Health Genomics at the U.S. Centers for Disease Control and Prevention. The Office was formed in 1998 and Dr Khoury served as the only ...

‘While molecular biomarkers such as genetics have proved valuable in the management of many diseases, the dynamic information provided by many physiological biomarkers will complement, enhance and ...

In Host genomics: lessons for infectious disease, we explore the potential of this complex field in tackling infectious disease. Based on our investigation of four major pathogens, we make ...

Making science work for health, the PHG Foundation podcast, examines the most promising developments in emerging biomedical technologies, such as gene editing, polygenic scores and long-read ...

Juliet is a General Practitioner and Associate Professor in the Department of Public Health and Primary Care in the University of Cambridge. Her main research focuses on optimising the implementation ...

This report outlines the case for further guidance and related support to healthcare professionals to maximise the possibility of genomic information being shared with all relevant family members.

Recent developments – at national and international levels – in the regulation and governance of data, AI and medical devices are having significant impacts and potential impacts on the application of ...

Our experienced staff, trustees and associates bring their specialist knowledge from a wide range of backgrounds to create interdisciplinary policy solutions to the practical challenges of translating ...